1. Home
  2. LGND vs SBCF Comparison

LGND vs SBCF Comparison

Compare LGND & SBCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • SBCF
  • Stock Information
  • Founded
  • LGND 1987
  • SBCF 1926
  • Country
  • LGND United States
  • SBCF United States
  • Employees
  • LGND 68
  • SBCF N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • SBCF Major Banks
  • Sector
  • LGND Health Care
  • SBCF Finance
  • Exchange
  • LGND Nasdaq
  • SBCF Nasdaq
  • Market Cap
  • LGND 3.2B
  • SBCF 3.0B
  • IPO Year
  • LGND 1992
  • SBCF N/A
  • Fundamental
  • Price
  • LGND $191.31
  • SBCF $30.30
  • Analyst Decision
  • LGND Strong Buy
  • SBCF Buy
  • Analyst Count
  • LGND 8
  • SBCF 3
  • Target Price
  • LGND $144.71
  • SBCF $31.00
  • AVG Volume (30 Days)
  • LGND 139.7K
  • SBCF 602.5K
  • Earning Date
  • LGND 08-05-2025
  • SBCF 10-27-2025
  • Dividend Yield
  • LGND N/A
  • SBCF 2.38%
  • EPS Growth
  • LGND N/A
  • SBCF 23.56
  • EPS
  • LGND N/A
  • SBCF 1.68
  • Revenue
  • LGND $181,488,000.00
  • SBCF $556,541,000.00
  • Revenue This Year
  • LGND $18.41
  • SBCF $28.39
  • Revenue Next Year
  • LGND $18.87
  • SBCF $34.82
  • P/E Ratio
  • LGND N/A
  • SBCF $18.04
  • Revenue Growth
  • LGND 53.40
  • SBCF 12.63
  • 52 Week Low
  • LGND $81.74
  • SBCF $21.36
  • 52 Week High
  • LGND $129.90
  • SBCF $32.33
  • Technical
  • Relative Strength Index (RSI)
  • LGND 66.71
  • SBCF 47.37
  • Support Level
  • LGND $182.87
  • SBCF $29.83
  • Resistance Level
  • LGND $194.44
  • SBCF $31.99
  • Average True Range (ATR)
  • LGND 5.79
  • SBCF 1.06
  • MACD
  • LGND -0.38
  • SBCF -0.00
  • Stochastic Oscillator
  • LGND 81.23
  • SBCF 50.44

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.

Share on Social Networks: